U.S. federal trademark · Serial No. 74707992
pharmaceutical preparations for the treatment of cancer, namely, monoclonal antibodies and radioisotopes for use in humans to combine the therapeutic effects of the monoclonal antibody and radioisotope
cancer therapy, namely, the use of monoclonal antibodies and radioisotopes in humans to combine the therapeutic effects of the monoclonal antibody and radioisotope
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.